These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37980219)

  • 21. Corticosteroids or non-corticosteroids: a fresh perspective on alcoholic hepatitis treatment.
    Wang F; Wang BY
    Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):458-64. PubMed ID: 21947718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of severe forms of alcoholic hepatitis: where are we going?
    Mathurin P; Louvet A; Dharancy S
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S60-2. PubMed ID: 18336666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.
    Singh S; Murad MH; Chandar AK; Bongiorno CM; Singal AK; Atkinson SR; Thursz MR; Loomba R; Shah VH
    Gastroenterology; 2015 Oct; 149(4):958-70.e12. PubMed ID: 26091937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis.
    Furuya S; Argemi J; Uehara T; Katou Y; Fouts DE; Schnabl B; Dubuquoy L; Belorkar A; Vadigepalli R; Kono H; Bataller R; Rusyn I
    Alcohol Clin Exp Res; 2020 Jan; 44(1):87-101. PubMed ID: 31710124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent updates on alcoholic hepatitis.
    Shipley LC; Kodali S; Singal AK
    Dig Liver Dis; 2019 Jun; 51(6):761-768. PubMed ID: 31010745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging medical therapies for severe alcoholic hepatitis.
    Tornai D; Szabo G
    Clin Mol Hepatol; 2020 Oct; 26(4):686-696. PubMed ID: 32981291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic Hepatitis.
    Singh V; Keisham A; Bhalla A; Sharma N; Agarwal R; Sharma R; Singh A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1650-1656.e2. PubMed ID: 29391265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis.
    Buzzetti E; Kalafateli M; Thorburn D; Davidson BR; Thiele M; Gluud LL; Del Giovane C; Askgaard G; Krag A; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011646. PubMed ID: 28368093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alcoholic Hepatitis: The Rising Epidemic.
    Penninti P; Adekunle AD; Singal AK
    Med Clin North Am; 2023 May; 107(3):533-554. PubMed ID: 37001952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy of acute alcoholic hepatitis in clinical practice.
    Abenavoli L; Milic N; Rouabhia S; Addolorato G
    World J Gastroenterol; 2014 Mar; 20(9):2159-67. PubMed ID: 24605014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Pharmacotherapies in Alcohol-Associated Hepatitis.
    Wakil A; Niazi M; Meybodi MA; Pyrsopoulos NT
    J Clin Exp Hepatol; 2023; 13(1):116-126. PubMed ID: 36647403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic and therapeutic strategies for severe alcoholic hepatitis].
    Kim W
    Korean J Gastroenterol; 2015 Jan; 65(1):4-11. PubMed ID: 25603848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.
    Fernandes SR; Marques da Costa P; Vítor S; Carvalho JR; Santos P; Moura CM; Cortez-Pinto H; Ramalho F; Velosa J
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1141-1148. PubMed ID: 28628497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comparative Study of Acute Alcoholic Hepatitis vs. Non-Alcoholic Hepatitis Patients from a Cohort with Chronic Alcohol Dependence.
    Tun KM; Dossaji Z; Massey BL; Batra K; Lo CH; Naga Y; Mohammed S; Muraga A; Gill A; Mukhopadhyay D; Singh A; Lankarani D; Aponte-Pieras J; Ohning G
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of severe alcoholic hepatitis: past, present and future.
    Lanthier N; Stärkel P
    Eur J Clin Invest; 2017 Jul; 47(7):531-539. PubMed ID: 28517024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis.
    Sehrawat TS; Arab JP; Liu M; Amrollahi P; Wan M; Fan J; Nakao Y; Pose E; Navarro-Corcuera A; Dasgupta D; Liao CY; He L; Mauer AS; Avitabile E; Ventura-Cots M; Bataller RA; Sanyal AJ; Chalasani NP; Heimbach JK; Watt KD; Gores GJ; Gines P; Kamath PS; Simonetto DA; Hu TY; Shah VH; Malhi H
    Hepatology; 2021 Feb; 73(2):571-585. PubMed ID: 32246544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Panchal SA; Kaplan DE; Goldberg DS; Mahmud N
    Dig Dis Sci; 2022 Sep; 67(9):4395-4402. PubMed ID: 35022905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttraumatic Stress Disorder in Patients with Heavy Alcohol Consumption and Alcoholic Hepatitis.
    Samala N; Lourens SG; Shah VH; Kamath PS; Sanyal AJ; Crabb DW; Tang Q; Radaeva S; Liangpunsakul S; Chalasani N
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1933-1938. PubMed ID: 30080255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular targets in the treatment of alcoholic hepatitis.
    Dhanda AD; Lee RW; Collins PL; McCune CA
    World J Gastroenterol; 2012 Oct; 18(39):5504-13. PubMed ID: 23112542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.